Oral [spco]
transdermal estrogen [horm, phsu, strd]
therapy [ftcn]
Lower [spco]
asymmetric [spco]
dimethylarginine [aapp]
Health [idcn]
postmenopausal [tmco]
Women [popg]
randomized [resa]
placebo controlled study [inpr, resa]
Objective [inpr]
To [qlco]
Compare [acty]
effects [qlco]
Oral [spco]
Transdermal [ftcn]
Hormone Therapy [topp]
asymmetric dimethylarginine [aapp, phsu]
Endogenous [ftcn]
Inhibitor [qlco]
Nitric Oxide Synthase [aapp, enzy]
postmenopausal [tmco]
Women [popg]
Design [acty]
placebo-controlled [resa]
Double-Blind Study [resa]
Health [idcn]
Women [popg]
randomized [resa]
To [qlco]
Receive [qlco]
Daily [tmco]
Transdermal [ftcn]
Te [elii, hops]
N NOS [aapp, imft]
Oral [spco]
Oe [qnco]
N NOS [aapp, imft]
Continuous [idcn]
Combined [qlco]
Gestodene [phsu, strd]
Oe [qnco]
g% [qnco]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
treatment [ftcn]
Cycle [tmco]
plasma concentration [qnco]
asymmetric dimethylarginine [aapp, phsu]
Arginine [aapp, bacs, phsu]
symmetric dimethylarginine [aapp]
Measured [qlco]
baseline [bodm]
In [qnco]
treatment [ftcn]
Cycle [tmco]
Chromatography, High Performance Liquid [lbpr]
Method [inpr]
Result [ftcn]
Cycle [tmco]
Active Treatment [topp]
Group [idcn]
Show [inpr]
reduction [npop]
asymmetric dimethylarginine [aapp, phsu]
Compared [acty]
placebo [topp]
Te [elii, hops]
Oe [qnco]
Oe [qnco]
g% [qnco]
ancova [qnco]
Show [inpr]
larger [qnco]
reduction [npop]
Oral [spco]
Group [idcn]
Compared [acty]
Transdermal [ftcn]
Group [idcn]
Te [elii, hops]
Oe [qnco]
Te [elii, hops]
Oe [qnco]
g% [qnco]
P NOS [aapp, imft]
Oral [spco]
Not [ftcn]
Transdermal [ftcn]
treatment [ftcn]
Reduced [qlco]
Arginine [aapp, bacs, phsu]
Compared [acty]
placebo [topp]
Active Treatment [topp]
Reduced [qlco]
symmetric dimethylarginine [aapp]
Only [qnco]
statistically significant [qnco]
Oe [qnco]
Group [idcn]
Conclusion [idcn]
reduction [npop]
asymmetric dimethylarginine [aapp, phsu]
More [ftcn]
Oral [spco]
Te [elii, hops]
Administration [ocac]
ADD [mobd]
Gestodene [phsu, strd]
Oral [spco]
Not [ftcn]
Altered [ftcn]
reduction [npop]
asymmetric dimethylarginine [aapp, phsu]
Clinical [qlco]
findings [ftcn]
Uncertain [idcn]
Decrease [qlco]
asymmetric dimethylarginine [aapp, phsu]
Phenomenon [phpr]
Modulation [spco]
nitric oxide synthesis [moft]
postmenopausal [tmco]
Hormone Therapy [topp]
